First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis

Graham Fent; Kulveer Mankia; Bara Erhayiem; Laura Hunt; Jacqueline Leong Nam; Lesley-Anne Bissell; James Rj Foley; Pei G Chew; Louise E Brown; John P Greenwood; Paul Emery; Sven Plein; Maya H Buch

doi:10.1136/annrheumdis-2018-214975

First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis

Graham Fent, Kulveer Mankia, Bara Erhayiem, Laura Hunt, Jacqueline Leong Nam, Lesley-Anne Bissell, James Rj Foley, Pei G Chew, Louise E Brown, John P Greenwood, Paul Emery, Sven Plein, Maya H Buch

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1138-1140
Number of pages	3
Journal	Annals of the rheumatic diseases
Volume	78
Issue number	8
DOIs	https://doi.org/10.1136/annrheumdis-2018-214975
Publication status	Published - Aug 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/annrheumdis-2018-214975

Cite this

Fent, G., Mankia, K., Erhayiem, B., Hunt, L., Nam, J. L., Bissell, L.-A., Foley, J. R., Chew, P. G., Brown, L. E., Greenwood, J. P., Emery, P., Plein, S., & Buch, M. H. (2019). First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. Annals of the rheumatic diseases, 78(8), 1138-1140. https://doi.org/10.1136/annrheumdis-2018-214975

@article{0c4b7e8b7b3a413a87a81937f657a27f,

title = "First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis",

author = "Graham Fent and Kulveer Mankia and Bara Erhayiem and Laura Hunt and Nam, {Jacqueline Leong} and Lesley-Anne Bissell and Foley, {James Rj} and Chew, {Pei G} and Brown, {Louise E} and Greenwood, {John P} and Paul Emery and Sven Plein and Buch, {Maya H}",

year = "2019",

month = aug,

doi = "10.1136/annrheumdis-2018-214975",

language = "English",

volume = "78",

pages = "1138--1140",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ ",

number = "8",

}

Fent, G, Mankia, K, Erhayiem, B, Hunt, L, Nam, JL, Bissell, L-A, Foley, JR, Chew, PG, Brown, LE, Greenwood, JP, Emery, P, Plein, S & Buch, MH 2019, 'First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis', Annals of the rheumatic diseases, vol. 78, no. 8, pp. 1138-1140. https://doi.org/10.1136/annrheumdis-2018-214975

First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis. / Fent, Graham; Mankia, Kulveer; Erhayiem, Bara et al.
In: Annals of the rheumatic diseases, Vol. 78, No. 8, 08.2019, p. 1138-1140.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis

AU - Fent, Graham

AU - Mankia, Kulveer

AU - Erhayiem, Bara

AU - Hunt, Laura

AU - Nam, Jacqueline Leong

AU - Bissell, Lesley-Anne

AU - Foley, James Rj

AU - Chew, Pei G

AU - Brown, Louise E

AU - Greenwood, John P

AU - Emery, Paul

AU - Plein, Sven

AU - Buch, Maya H

PY - 2019/8

Y1 - 2019/8

U2 - 10.1136/annrheumdis-2018-214975

DO - 10.1136/annrheumdis-2018-214975

M3 - Letter

C2 - 30852551

SN - 0003-4967

VL - 78

SP - 1138

EP - 1140

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 8

ER -